Factors influencing the anxiety and depression status in patients undergoing in vitro fertilization-embryo transfer assisted pregnancy

Women undergoing in vitro fertilization-embryo transfer (IVF-ET) can suffer from anxiety and depression at various levels during the process. This study aimed to assess the anxiety and depression statuses (primary outcome) and influencing factors (secondary outcome) among patients undergoing IVF-ET. A 2019–2020 survey at Northwest Women’s and Children’s Hospital studied IVF-ET patients, evaluating anxiety and depression with GAD-7 and PHQ-9 alongside demographic data, using logistic regression for influencing factors. Among the 2465 women who undergoing IVF-ET, 27.18% had depression, and 18.46% had anxiety. Bachelors’ degree (OR = 0.659, 95%CI: 0.503–0.864), male factor infertility (OR = 0.745, 95%CI: 0.558–0.995), and assessment on the day of starting gonadotropin stimulation (OR = 0.781, 95%CI: 0.626–0.974) were negatively independently associated with depression, while comorbidities (OR = 1.541, 95%CI: 1.281–1.854) and an extended ART strategy (OR = 1.394, 95%CI: 1.162–1.672) were independently associated with depression. High school/technical school education (OR = 0.669, 95%CI: 0.490–0.915) and bachelor’s degree (OR = 0.640, 95%CI: 0.472–0.868) were negatively independently associated with anxiety, while an extended ART strategy (OR = 1.476, 95%CI: 1.197–1.820) was independently associated with anxiety. In conclusion, the prevalence of depression and anxiety was high in women undergoing IVF-ET. The study identified factors independently associated with depression and anxiety that could be used to guide the psychological management of women undergoing IVF-ET.